Latest / Stock Movers / Novo Nordisk Rises, GoodRX Surges, CVS Gains on UBS Upgrade
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:18Speaker 2: the move today. I'm Paul swinging alongside Lis Mittel. I'm
- 0:20Speaker 2: joined by Bloomberg's Tatiana Daria Tatiana. What are you looking
- 0:23Speaker 2: at today? Well, starting off with Novo Nordisk, which is
- 0:27Speaker 2: ADRs are up about a four percent. Your tickers and
- 0:31Speaker 2: vo and I know you guys just discussed the story.
- 0:33Speaker 2: But what is interesting to me is that it all
- 0:36Speaker 2: comes after President Trump has been putting pressure on farmat
- 0:39Speaker 2: companies to lower drug costs. So the company slash the
- 0:43Speaker 2: cost of ozempic for cash bank patients to four ninety
- 0:46Speaker 2: nine a month, about half of its US list pricing
- 0:49Speaker 2: that this move really caters to patients who don't have insurance.
- 0:54Speaker 2: So it looks like maybe companies are trying to work
- 0:58Speaker 2: with the president here to avoid more public shaming, because
- 1:01Speaker 2: Eli Lilly also last week raised the list price for
- 1:04Speaker 2: its abusity shot shot in the UK by as much
- 1:07Speaker 2: as one hundred and seventy percent, as President Trump also
- 1:11Speaker 2: asked companies to increase prices in Europe and to lower
- 1:14Speaker 2: them for Americans. Well, for the record, Novo said that
- 1:17Speaker 2: the offer is unrelated to discussions with the US government.
- 1:21Speaker 2: And it's also worth noting that the stock was rallying
- 1:24Speaker 2: there a little bit even before the news as we go,
- 1:27Speaker 2: VI received the FDA approval to treat a serious form
- 1:30Speaker 2: of liver disease. So it looks like there is different
- 1:33Speaker 2: parts here, but it's interesting to follow sort of that
- 1:37Speaker 2: the government or Trump's push to load drug pricing and
- 1:41Speaker 2: if that is really having an impact already, and then
- 1:44Speaker 2: good rex is this tied into Novo Nordics definitely tied
- 1:48Speaker 2: to this story. You know the company and the stock
- 1:51Speaker 2: is up thirty three percent right now. The ticker is
- 1:54Speaker 2: gd r X. The CEO and Bloomberg TV making the
- 1:58Speaker 2: case for the company this morning, explain really how this
- 2:01Speaker 2: company works, because a lot of people had questions, and
- 2:04Speaker 2: it says that it's a digital marketplace for drugs pricing.
- 2:08Speaker 2: It really doesn't fulfill or dispense the drugs, but it
- 2:12Speaker 2: negotiates the most competitive prices with insurance and analysts are
- 2:16Speaker 2: saying that this deal with Nova Nordisk will allow the
- 2:19Speaker 2: company to monetize about seventeen million patients looking for GLP ones,
- 2:25Speaker 2: So huge opportunity there for them. Right. What else, well,
- 2:29Speaker 2: staying with the pharma space, looking at cbs UBS upgrading
- 2:33Speaker 2: the stock here ticker is see the as up about
- 2:37Speaker 2: three percent, the analyst writing that the upgrade follows two
- 2:41Speaker 2: strong consecutive quarters and early sign that the healthcare benefits
- 2:44Speaker 2: segment fixes are on track. As a reminder, the company
- 2:48Speaker 2: is exiting the Obamacare individual health insurance exchange market next year,
- 2:53Speaker 2: and it is focusing on higher margin segments like Medicare advantage,
- 2:57Speaker 2: and it looks like that is really catching analysts attention
- 3:01Speaker 2: because this upgrade comes after a similar boost from Baird
- 3:05Speaker 2: on Friday. The stock now has twenty three buys, six holds,
- 3:09Speaker 2: and no sales poll and the average price target is
- 3:13Speaker 2: eighty one dollars, signaling analysts sea growth potential because we're
- 3:16Speaker 2: trading at seventy dollars and sixty six cents right now.
- 3:20Speaker 1: The Stock Movers report from Bloomberg Radio. Check back with
- 3:25Speaker 1: us throughout the day for the latest roundup of companies
- 3:27Speaker 1: making news on Wall Street and for the latest market
- 3:30Speaker 1: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
- 3:35Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:38Speaker 1: the Bloomberg Business app.